However, their use in MP has not been explored yet
[26] Which pathway applies to you depends on why Wegovy is prescribed and which Medicare plan you have: For weight loss: The Medicare GLP-1 Bridge now covers all Wegovy forms at $50/month for eligible Part D beneficiaries (BMI-based criteria + prior authorization) For cardiovascular risk reduction: May be covered under Part D via the CV indication (SELECT trial)this routes through your Part D plan, not the Bridge [26] Medicare Advantage: Coverage for the CV indication varies by plan Bottom line: Medicare beneficiaries now have a real weight-loss pathway for Wegovythe $50 Bridge (all forms)plus the long-standing Part D coverage for the cardiovascular indication
Anchor-compound logic
Pickart, L., Vasquez-Soltero, J., Pickart, F., & Majnarich, J
In other words, semaglutide helps reduce the calories you consume and store, while sermorelin helps your body use those calories more effectively
C., da Costa Leite, C., Lancha-Junior, A